On the evening of May 25, Ali Health announced its full-year results for the year ended March 31, 2022.
The announcement shows that ali Health achieved operating revenue of 20.578 billion yuan in the reporting period, a year-on-year growth of 32.6%; Gross profit of 4.108 billion yuan, but the gross margin decreased by 3.3 percentage points to 20%; The adjusted net loss was 394 million yuan, and the adjusted profit for the same period of fiscal year 2021 was 631 million yuan, which turned into a loss year-on-year, and the profit decreased by more than 1 billion yuan.
For the decline of gross margin, Ali Health said that it was mainly due to the decrease in the proportion of the business revenue of the medical e-commerce platform with higher gross margin; Improving the market share of online B2C drugs will affect the reduction of the gross profit margin of self-operated medicine business; And the prescription drug business with lower gross margins grew significantly and increased revenue as a percentage.
It is worth noting that in fiscal year 2022, Ali Health's sales and marketing expenses increased significantly, increasing by 759 million yuan year-on-year to 1.981 billion yuan, an increase of 62.1%.
In this regard, Ali Health said that the main reason is to increase investment in tmall medicine platform and Ali health big pharmacy brand mental construction; To increase the market share of online B2C drug sales and accelerate the prescription drug business layout, increase the corresponding market release; And continue to increase investment in sales and operation personnel, local medical, medical deer APP and other innovative business operation personnel.
According to the official website, Ali Health's business mainly focuses on pharmaceutical e-commerce and new retail, Internet medical care, consumer medical care, smart medical care and other fields, while providing comprehensive online and offline integration solutions for the big health industry. As of The close of May 25, Ali Health has a total market value of 51.368 billion Hong Kong dollars, about 43.8 billion yuan. (Cheng Ho-kwan)